WHO ICTRP trial
A study designed to test a new oxygen delivery device (NHFO2) in patients with…
ACTRN12617001278325 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12617001278325 |
|---|---|
| Public title | A study designed to test a new oxygen delivery device (NHFO2) in patients with long term respiratory disease who require home oxygen. |
| Scientific title | A study designed to test the ability of a novel oxygen delivery system (NHFO2) to autotitrate the delivered inspired oxygen concentration (FiO2) to a target arterial oxygen saturation (SpO2) in participants with chronic respiratory disease on long term oxygen therapy (LTOT). |
| Primary sponsor | Fisher and Paykel Healthcare Limited |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | New Zealand |
| Conditions | Chronic obstructive pulmonary disease (COPD);Interstitial lung disease;Bronchiectasis;Any other doctor diagnosed chronic respiratory condition with requirement for long term oxygen therapy (LTOT); Chronic obstructive pulmonary disease… |
| Interventions | This study assesses the performance of a novel oxygen delivery device called a nasal high flow oxygen titration device (NHFO2). This is a newly developed device which delivers heated, humidified high flow oxygen via nasal cannulae at an… |
| Registration date | Jun 9, 2017 |
| Target size | 12 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: